Skip to main content
In stock | Cellular Therapy (CAR-T)

Anitocabtagene Autoleucel

Oncology Type Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism Chimeric Antigen Receptor T-Cell Therapy
No Image
Description

Anitocabtagene Autoleucel is classified as a Chimeric Antigen Receptor T-Cell Therapy, sourced for use within our Cellular Therapy (CAR-T) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Cellular Therapy (CAR-T)
Oncology Type Hematologic (Leukemia/Lymphoma/Myeloma)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3